APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pefloxacin Mesylate

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pefloxacin Mesylate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026184 pages

Choose your research edition.

Industry ResearchPefloxacin Mesylate Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Pefloxacin Mesylate Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Pefloxacin Mesylate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pefloxacin Mesylate Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Pefloxacin Mesylate Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Pefloxacin Mesylate market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pefloxacin Mesylate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pefloxacin Mesylate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pefloxacin Mesylate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pefloxacin Mesylate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pefloxacin Mesylate include AdvaCare Pharma, Beijing Shuanglu Pharmaceutical Co., Ltd., Beijing Sihuan Pharmaceutical Co., Ltd., China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd., CommScope Pharmaceutical Co., Ltd., Ruiyang Pharmaceutical Co., Ltd., Shandong Lukang Pharmaceutical Group Saite Co., Ltd. and Yichang Renfu Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pefloxacin Mesylate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pefloxacin Mesylate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pefloxacin Mesylate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pefloxacin Mesylate market size, projected growth trends, production technologies, key applications, and end-use industries.

Pefloxacin Mesylate Segment by Company

AdvaCare Pharma

Beijing Shuanglu Pharmaceutical Co., Ltd.

Beijing Sihuan Pharmaceutical Co., Ltd.

China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd.

CommScope Pharmaceutical Co., Ltd.

Ruiyang Pharmaceutical Co., Ltd.

Shandong Lukang Pharmaceutical Group Saite Co., Ltd.

Yichang Renfu Pharmaceutical Co., Ltd.

Pefloxacin Mesylate Segment by Type

Capsule

Tablet

Injection

Pefloxacin Mesylate Segment by Application

Hospital Pharmacy

Retail Pharmacy

Others

Pefloxacin Mesylate Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pefloxacin Mesylate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pefloxacin Mesylate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pefloxacin Mesylate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pefloxacin Mesylate market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pefloxacin Mesylate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pefloxacin Mesylate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pefloxacin Mesylate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pefloxacin Mesylate Industry Trends Table 2. Pefloxacin Mesylate Industry Drivers Table 3. Pefloxacin Mesylate Industry Opportunities and Challenges Table 4. Pefloxacin Mesylate Industry Restraints Table 5. Global Pefloxacin Mesylate Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pefloxacin Mesylate Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pefloxacin Mesylate Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Pefloxacin Mesylate Sales Market Share by Manufacturers Table 9. Global Pefloxacin Mesylate Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Pefloxacin Mesylate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pefloxacin Mesylate Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pefloxacin Mesylate Manufacturers, Product Type & Application Table 13. Global Pefloxacin Mesylate Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pefloxacin Mesylate by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Capsule Table 17. Major Manufacturers of Tablet Table 18. Major Manufacturers of Injection Table 19. Global Pefloxacin Mesylate Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Pefloxacin Mesylate Sales by Type (2021-2026) & (K Units) Table 21. Global Pefloxacin Mesylate Sales by Type (2027-2032) & (K Units) Table 22. Global Pefloxacin Mesylate Sales Market Share by Type (2021-2026) Table 23. Global Pefloxacin Mesylate Sales Market Share by Type (2027-2032) Table 24. Global Pefloxacin Mesylate Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Pefloxacin Mesylate Revenue by Type (2021-2026) & (K Units) Table 26. Global Pefloxacin Mesylate Revenue by Type (2027-2032) & (K Units) Table 27. Global Pefloxacin Mesylate Revenue Market Share by Type (2021-2026) Table 28. Global Pefloxacin Mesylate Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Pharmacy Table 30. Major Manufacturers of Retail Pharmacy Table 31. Major Manufacturers of Others Table 32. Global Pefloxacin Mesylate Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Pefloxacin Mesylate Sales by Application (2021-2026) & (K Units) Table 34. Global Pefloxacin Mesylate Sales by Application (2027-2032) & (K Units) Table 35. Global Pefloxacin Mesylate Sales Market Share by Application (2021-2026) Table 36. Global Pefloxacin Mesylate Sales Market Share by Application (2027-2032) Table 37. Global Pefloxacin Mesylate Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Pefloxacin Mesylate Revenue by Application (2021-2026) & (K Units) Table 39. Global Pefloxacin Mesylate Revenue by Application (2027-2032) & (K Units) Table 40. Global Pefloxacin Mesylate Revenue Market Share by Application (2021-2026) Table 41. Global Pefloxacin Mesylate Revenue Market Share by Application (2027-2032) Table 42. Global Pefloxacin Mesylate Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Pefloxacin Mesylate Sales by Region (2021-2026) & (K Units) Table 44. Global Pefloxacin Mesylate Sales Market Share by Region (2021-2026) Table 45. Global Pefloxacin Mesylate Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Pefloxacin Mesylate Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Pefloxacin Mesylate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Pefloxacin Mesylate Sales by Country (2021-2026) & (K Units) Table 49. North America Pefloxacin Mesylate Sales by Country (2027-2032) & (K Units) Table 50. Europe Pefloxacin Mesylate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Pefloxacin Mesylate Sales by Country (2021-2026) & (K Units) Table 52. Europe Pefloxacin Mesylate Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Pefloxacin Mesylate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Pefloxacin Mesylate Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Pefloxacin Mesylate Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Pefloxacin Mesylate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Pefloxacin Mesylate Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Pefloxacin Mesylate Sales by Country (2027-2032) & (K Units) Table 59. Global Pefloxacin Mesylate Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Pefloxacin Mesylate Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Pefloxacin Mesylate Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Pefloxacin Mesylate Revenue Market Share by Region (2021-2026) Table 63. Global Pefloxacin Mesylate Revenue Market Share by Region (2027-2032) Table 64. AdvaCare Pharma Company Information Table 65. AdvaCare Pharma Business Overview Table 66. AdvaCare Pharma Pefloxacin Mesylate Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. AdvaCare Pharma Pefloxacin Mesylate Product Portfolio Table 68. AdvaCare Pharma Recent Development Table 69. Beijing Shuanglu Pharmaceutical Co., Ltd. Company Information Table 70. Beijing Shuanglu Pharmaceutical Co., Ltd. Business Overview Table 71. Beijing Shuanglu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Beijing Shuanglu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Portfolio Table 73. Beijing Shuanglu Pharmaceutical Co., Ltd. Recent Development Table 74. Beijing Sihuan Pharmaceutical Co., Ltd. Company Information Table 75. Beijing Sihuan Pharmaceutical Co., Ltd. Business Overview Table 76. Beijing Sihuan Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Beijing Sihuan Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Portfolio Table 78. Beijing Sihuan Pharmaceutical Co., Ltd. Recent Development Table 79. China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Company Information Table 80. China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Business Overview Table 81. China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Pefloxacin Mesylate Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Pefloxacin Mesylate Product Portfolio Table 83. China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Recent Development Table 84. CommScope Pharmaceutical Co., Ltd. Company Information Table 85. CommScope Pharmaceutical Co., Ltd. Business Overview Table 86. CommScope Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. CommScope Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Portfolio Table 88. CommScope Pharmaceutical Co., Ltd. Recent Development Table 89. Ruiyang Pharmaceutical Co., Ltd. Company Information Table 90. Ruiyang Pharmaceutical Co., Ltd. Business Overview Table 91. Ruiyang Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Ruiyang Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Portfolio Table 93. Ruiyang Pharmaceutical Co., Ltd. Recent Development Table 94. Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Company Information Table 95. Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Business Overview Table 96. Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Pefloxacin Mesylate Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Pefloxacin Mesylate Product Portfolio Table 98. Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Recent Development Table 99. Yichang Renfu Pharmaceutical Co., Ltd. Company Information Table 100. Yichang Renfu Pharmaceutical Co., Ltd. Business Overview Table 101. Yichang Renfu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Yichang Renfu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Portfolio Table 103. Yichang Renfu Pharmaceutical Co., Ltd. Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Pefloxacin Mesylate Distributors List Table 107. Pefloxacin Mesylate Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Pefloxacin Mesylate Product Image Figure 2. Global Pefloxacin Mesylate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pefloxacin Mesylate Market Size (2021-2032) & (US$ Million) Figure 4. Global Pefloxacin Mesylate Sales (2021-2032) & (K Units) Figure 5. Global Pefloxacin Mesylate Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pefloxacin Mesylate Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Capsule Image Figure 9. Tablet Image Figure 10. Injection Image Figure 11. Global Pefloxacin Mesylate Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Pefloxacin Mesylate Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Pefloxacin Mesylate Sales Market Share by Type (2021-2032) Figure 14. Global Pefloxacin Mesylate Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Pefloxacin Mesylate Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Pefloxacin Mesylate Revenue Market Share by Type (2021-2032) Figure 17. Hospital Pharmacy Image Figure 18. Retail Pharmacy Image Figure 19. Others Image Figure 20. Global Pefloxacin Mesylate Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Pefloxacin Mesylate Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Pefloxacin Mesylate Sales Market Share by Application (2021-2032) Figure 23. Global Pefloxacin Mesylate Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Pefloxacin Mesylate Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Pefloxacin Mesylate Revenue Market Share by Application (2021-2032) Figure 26. North America Pefloxacin Mesylate Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Pefloxacin Mesylate Sales Market Share by Country (2021-2032) Figure 28. U.S. Pefloxacin Mesylate Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Pefloxacin Mesylate Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Pefloxacin Mesylate Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Pefloxacin Mesylate Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Pefloxacin Mesylate Sales Market Share by Country (2021-2032) Figure 33. Germany Pefloxacin Mesylate Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Pefloxacin Mesylate Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Pefloxacin Mesylate Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Pefloxacin Mesylate Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Pefloxacin Mesylate Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Pefloxacin Mesylate Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Pefloxacin Mesylate Sales Market Share by Country (2021-2032) Figure 40. China Pefloxacin Mesylate Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Pefloxacin Mesylate Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Pefloxacin Mesylate Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Pefloxacin Mesylate Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Pefloxacin Mesylate Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Pefloxacin Mesylate Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Pefloxacin Mesylate Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Pefloxacin Mesylate Sales Market Share by Country (2021-2032) Figure 48. Brazil Pefloxacin Mesylate Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Pefloxacin Mesylate Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Pefloxacin Mesylate Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Pefloxacin Mesylate Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Pefloxacin Mesylate Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Pefloxacin Mesylate Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Pefloxacin Mesylate Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Pefloxacin Mesylate Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Pefloxacin Mesylate Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Pefloxacin Mesylate Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Pefloxacin Mesylate Revenue (2021-2032) & (US$ Million) Figure 59. North America Pefloxacin Mesylate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Pefloxacin Mesylate Revenue (2021-2032) & (US$ Million) Figure 61. Europe Pefloxacin Mesylate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Pefloxacin Mesylate Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Pefloxacin Mesylate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Pefloxacin Mesylate Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Pefloxacin Mesylate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Pefloxacin Mesylate Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Pefloxacin Mesylate Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Tablet
  • Injection
Applications
  • Hospital Pharmacy
  • Retail Pharmacy
  • Others
Companies covered
  • AdvaCare Pharma
  • Beijing Shuanglu Pharmaceutical Co., Ltd.
  • Beijing Sihuan Pharmaceutical Co., Ltd.
  • China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd.
  • CommScope Pharmaceutical Co., Ltd.
  • Ruiyang Pharmaceutical Co., Ltd.
  • Shandong Lukang Pharmaceutical Group Saite Co., Ltd.
  • Yichang Renfu Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pefloxacin Mesylate Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pefloxacin Mesylate Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pefloxacin Mesylate Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pefloxacin Mesylate Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pefloxacin Mesylate Market Dynamics
  1. 2.1 Pefloxacin Mesylate Industry Trends
  2. 2.2 Pefloxacin Mesylate Industry Drivers
  3. 2.3 Pefloxacin Mesylate Industry Opportunities and Challenges
  4. 2.4 Pefloxacin Mesylate Industry Restraints
3 Pefloxacin Mesylate Market by Manufacturers
  1. 3.1 Global Pefloxacin Mesylate Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pefloxacin Mesylate Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pefloxacin Mesylate Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pefloxacin Mesylate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pefloxacin Mesylate Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pefloxacin Mesylate Manufacturers, Product Type & Application
  7. 3.7 Global Pefloxacin Mesylate Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pefloxacin Mesylate Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pefloxacin Mesylate Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pefloxacin Mesylate Tier 1, Tier 2, and Tier 3
4 Pefloxacin Mesylate Market by Type
  1. 4.1 Pefloxacin Mesylate Type Introduction
  2. 4.1.1 Capsule
  3. 4.1.2 Tablet
  4. 4.1.3 Injection
  5. 4.2 Global Pefloxacin Mesylate Sales by Type
  6. 4.2.1 Global Pefloxacin Mesylate Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Pefloxacin Mesylate Sales by Type (2021-2032)
  8. 4.2.3 Global Pefloxacin Mesylate Sales Market Share by Type (2021-2032)
  9. 4.3 Global Pefloxacin Mesylate Revenue by Type
  10. 4.3.1 Global Pefloxacin Mesylate Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Pefloxacin Mesylate Revenue by Type (2021-2032)
  12. 4.3.3 Global Pefloxacin Mesylate Revenue Market Share by Type (2021-2032)
5 Pefloxacin Mesylate Market by Application
  1. 5.1 Pefloxacin Mesylate Application Introduction
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 Others
  5. 5.2 Global Pefloxacin Mesylate Sales by Application
  6. 5.2.1 Global Pefloxacin Mesylate Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pefloxacin Mesylate Sales by Application (2021-2032)
  8. 5.2.3 Global Pefloxacin Mesylate Sales Market Share by Application (2021-2032)
  9. 5.3 Global Pefloxacin Mesylate Revenue by Application
  10. 5.3.1 Global Pefloxacin Mesylate Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pefloxacin Mesylate Revenue by Application (2021-2032)
  12. 5.3.3 Global Pefloxacin Mesylate Revenue Market Share by Application (2021-2032)
6 Global Pefloxacin Mesylate Sales by Region
  1. 6.1 Global Pefloxacin Mesylate Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pefloxacin Mesylate Sales by Region (2021-2032)
  3. 6.2.1 Global Pefloxacin Mesylate Sales by Region (2021-2026)
  4. 6.2.2 Global Pefloxacin Mesylate Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pefloxacin Mesylate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pefloxacin Mesylate Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pefloxacin Mesylate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pefloxacin Mesylate Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pefloxacin Mesylate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pefloxacin Mesylate Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pefloxacin Mesylate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pefloxacin Mesylate Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pefloxacin Mesylate Revenue by Region
  1. 7.1 Global Pefloxacin Mesylate Revenue by Region
  2. 7.1.1 Global Pefloxacin Mesylate Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pefloxacin Mesylate Revenue by Region (2021-2026)
  4. 7.1.3 Global Pefloxacin Mesylate Revenue by Region (2027-2032)
  5. 7.1.4 Global Pefloxacin Mesylate Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pefloxacin Mesylate Revenue (2021-2032)
  8. 7.2.2 North America Pefloxacin Mesylate Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pefloxacin Mesylate Revenue (2021-2032)
  11. 7.3.2 Europe Pefloxacin Mesylate Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pefloxacin Mesylate Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pefloxacin Mesylate Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pefloxacin Mesylate Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pefloxacin Mesylate Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AdvaCare Pharma
  2. 8.1.1 AdvaCare Pharma Company Information
  3. 8.1.2 AdvaCare Pharma Business Overview
  4. 8.1.3 AdvaCare Pharma Pefloxacin Mesylate Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AdvaCare Pharma Pefloxacin Mesylate Product Portfolio
  6. 8.1.5 AdvaCare Pharma Recent Developments
  7. 8.2 Beijing Shuanglu Pharmaceutical Co., Ltd.
  8. 8.2.1 Beijing Shuanglu Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Beijing Shuanglu Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Beijing Shuanglu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Beijing Shuanglu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Portfolio
  12. 8.2.5 Beijing Shuanglu Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Beijing Sihuan Pharmaceutical Co., Ltd.
  14. 8.3.1 Beijing Sihuan Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Beijing Sihuan Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Beijing Sihuan Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Beijing Sihuan Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Portfolio
  18. 8.3.5 Beijing Sihuan Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd.
  20. 8.4.1 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Company Information
  21. 8.4.2 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Business Overview
  22. 8.4.3 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Pefloxacin Mesylate Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Pefloxacin Mesylate Product Portfolio
  24. 8.4.5 China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. Recent Developments
  25. 8.5 CommScope Pharmaceutical Co., Ltd.
  26. 8.5.1 CommScope Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 CommScope Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 CommScope Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CommScope Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Portfolio
  30. 8.5.5 CommScope Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Ruiyang Pharmaceutical Co., Ltd.
  32. 8.6.1 Ruiyang Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Ruiyang Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Ruiyang Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Ruiyang Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Portfolio
  36. 8.6.5 Ruiyang Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Shandong Lukang Pharmaceutical Group Saite Co., Ltd.
  38. 8.7.1 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Company Information
  39. 8.7.2 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Business Overview
  40. 8.7.3 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Pefloxacin Mesylate Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Pefloxacin Mesylate Product Portfolio
  42. 8.7.5 Shandong Lukang Pharmaceutical Group Saite Co., Ltd. Recent Developments
  43. 8.8 Yichang Renfu Pharmaceutical Co., Ltd.
  44. 8.8.1 Yichang Renfu Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Yichang Renfu Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Yichang Renfu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Yichang Renfu Pharmaceutical Co., Ltd. Pefloxacin Mesylate Product Portfolio
  48. 8.8.5 Yichang Renfu Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pefloxacin Mesylate Value Chain Analysis
  2. 9.1.1 Pefloxacin Mesylate Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pefloxacin Mesylate Production Mode & Process
  6. 9.2 Pefloxacin Mesylate Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pefloxacin Mesylate Distributors
  9. 9.2.3 Pefloxacin Mesylate Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst